Home

SCOTT A. MACKE

CIK 1661765 · See Remarks · last filed 2017-10-11

SCOTT A. MACKE is a corporate insider who has filed 8 SEC Form 4 insider transactions across 2 companies since 2016. The most recent filing, for AVDL, was dated Oct 11, 2017.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

2

Total Filings

8

Lifetime Open-Market Net

$0

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
AVADEL PHARMACEUTICALS PLC (AVDL) Delisted See Remarks 56,000 $21.64 $1.21M $0 3 2017-10-11
AVADEL PHARMACEUTICALS PLC (FLML) Delisted See Remarks 52,000 — — $0 5 2017-01-03

Recent Filings

8 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2017-10-11 AVADEL PHARMACEUTICALS PLC (AVDL) Delisted — — $0 EDGAR
2017-02-15 AVADEL PHARMACEUTICALS PLC (AVDL) Delisted Grant (A) +56,000 $0 EDGAR
2017-01-13 AVADEL PHARMACEUTICALS PLC (AVDL) Delisted Grant (A) +52,000 $0 EDGAR
2017-01-03 AVADEL PHARMACEUTICALS PLC (FLML) Delisted Grant (A) +52,000 $0 EDGAR
2017-01-03 AVADEL PHARMACEUTICALS PLC (FLML) Delisted Disp (D) −52,000 $0 EDGAR
2016-12-16 AVADEL PHARMACEUTICALS PLC (FLML) Delisted Grant (A) +18,000 $0 EDGAR
2016-12-16 AVADEL PHARMACEUTICALS PLC (FLML) Delisted Grant (A) +10,000 $0 EDGAR
2016-08-12 AVADEL PHARMACEUTICALS PLC (FLML) Delisted Grant (A) +15,000 $0 EDGAR
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.